Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 12 studies | 70% ± 22% | |
GABAergic neuron | 10 studies | 57% ± 29% | |
endothelial cell | 6 studies | 30% ± 16% | |
cardiac muscle cell | 6 studies | 56% ± 24% | |
retinal ganglion cell | 5 studies | 38% ± 23% | |
fibroblast | 5 studies | 30% ± 15% | |
smooth muscle cell | 5 studies | 30% ± 7% | |
interneuron | 5 studies | 69% ± 24% | |
neuron | 4 studies | 34% ± 12% | |
amacrine cell | 4 studies | 27% ± 2% | |
GABAergic amacrine cell | 3 studies | 28% ± 5% | |
granule cell | 3 studies | 80% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 95% | 2410.29 | 232 / 245 | 97% | 27.42 | 485 / 502 |
ovary | 100% | 4686.67 | 180 / 180 | 77% | 17.67 | 332 / 430 |
brain | 88% | 5488.31 | 2314 / 2642 | 76% | 20.48 | 537 / 705 |
thymus | 83% | 1423.75 | 541 / 653 | 79% | 17.75 | 479 / 605 |
adrenal gland | 80% | 1190.69 | 207 / 258 | 37% | 12.58 | 84 / 230 |
lung | 90% | 1472.20 | 518 / 578 | 25% | 2.24 | 289 / 1155 |
uterus | 81% | 1774.94 | 138 / 170 | 21% | 7.31 | 95 / 459 |
esophagus | 80% | 2328.17 | 1151 / 1445 | 19% | 1.12 | 34 / 183 |
bladder | 81% | 3341.10 | 17 / 21 | 13% | 1.25 | 67 / 504 |
blood vessel | 94% | 2364.22 | 1255 / 1335 | 0% | 0 | 0 / 0 |
intestine | 66% | 1523.09 | 638 / 966 | 6% | 0.51 | 34 / 527 |
kidney | 51% | 543.74 | 45 / 89 | 16% | 12.62 | 142 / 901 |
pancreas | 30% | 270.14 | 100 / 328 | 32% | 1.58 | 57 / 178 |
heart | 56% | 2267.91 | 480 / 861 | 0% | 0 | 0 / 0 |
stomach | 14% | 141.04 | 49 / 359 | 14% | 1.50 | 39 / 286 |
breast | 13% | 123.30 | 58 / 459 | 12% | 1.37 | 130 / 1118 |
spleen | 24% | 204.45 | 57 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 22% | 8.60 | 10 / 45 |
adipose | 21% | 218.76 | 249 / 1204 | 0% | 0 | 0 / 0 |
muscle | 20% | 253.37 | 161 / 803 | 0% | 0 | 0 / 0 |
skin | 6% | 47.42 | 103 / 1809 | 2% | 0.20 | 9 / 472 |
liver | 0% | 0 | 0 / 226 | 3% | 0.32 | 12 / 406 |
eye | 0% | 0 | 0 / 0 | 3% | 0.41 | 2 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006493 | Biological process | protein O-linked glycosylation |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0004653 | Molecular function | polypeptide N-acetylgalactosaminyltransferase activity |
GO_0030246 | Molecular function | carbohydrate binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | GALNT17 |
Protein name | Polypeptide N-acetylgalactosaminyltransferase 17 Polypeptide N-acetylgalactosaminyltransferase 17 (EC 2.4.1.41) (Polypeptide GalNAc transferase-like protein 3) (GalNAc-T-like protein 3) (pp-GaNTase-like protein 3) (Protein-UDP acetylgalactosaminyltransferase-like protein 3) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 3) (Williams-Beuren syndrome chromosomal region 17 protein) Polypeptide N-acetylgalactosaminyltransferase (EC 2.4.1.-) (Protein-UDP acetylgalactosaminyltransferase) |
Synonyms | WBSCR17 GALNT19 tcag7.519 hCG_19354 |
Description | FUNCTION: May catalyze the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor. . |
Accessions | H7BZX9 ENST00000333538.10 Q2L4S5 ENST00000447516.5 Q6IS24 |